43827 Deucravacitinib Long-term Efficacy in Patients Originally Randomized to Placebo: 2-Year Results From the POETYK PSO Program

Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2023
This article has no abstract
Epistemonikos ID: e4d50048182453a219d9f6f41b11fa0ddd86098c
First added on: Dec 07, 2023